Drugs That Fight Herpes May Thwart Alzheimer’s Disease

Via Scoop.itHealthcare Continuing Education

The herpes simplex virus type 1 (HSV1), the virus that causes most cold sores, has previously been tied to the development of Alzheimer’s disease. Antiviral drugs used to combat herpes virus infections could slow the progression of Alzheimer’s disease, a new study suggests.
Show original

Enhanced by Zemanta

Will We Cure Alzheimer’s?

Via Scoop.itHealthcare Continuing Education

At first, Alzheimer’s was regarded as a subcategory of dementia. But, more and more, the label came to apply to ALL older people who “lost their wits,” as the experience used to be described. And, with the greater diseasification, came the hope–the belief–that senility was on the verge of being cured.
Show original

Enhanced by Zemanta

Depression in Later Life a Harbinger of Dementia

Late-life depression, occurring after age 50 years, is associated with a significantly increased risk for dementia, and in fact may be an early sign of cognitive decline, new research shows.

“Studies such as the Rotterdam [Scan] Study in the Netherlands have found that people who had early-life depression had a risk of Alzheimer disease in later life,” lead author Ge Li, MD, PhD, from the University of Washington, Seattle, told Medscape Medical News.

“But is depression causing dementia, or is it an early symptom of dementia? We wanted to explore the temporal relationship between the 2 conditions,” Dr. Li added.

The study is published in the September issue of the Archives of General Psychiatry.

Early Manifestation of Dementia?

The investigators used data from the Adult Changes in Thought study, a large, community-based, prospective study of people aged 65 years and older who were free of dementia at baseline, and who were followed-up every 2 years for up to 15 years.

Participants in the study were Seattle-area members of the Group Health Cooperative health maintenance organization. The study had 3 phases of enrolment.

The first cohort of 2581 participants was recruited in 1994 to1996, 811 participants were enrolled in 2000 to 2002, and another 709 participants were enrolled in 2004 to maintain a cohort of more than 2000 participants at risk for dementia in each calendar year.

Baseline depression was assessed with the Center for Epidemiologic Studies Depression Scale, and participants who scored 11 or greater were deemed to have significant depressive symptoms. The participants were also asked whether they had suffered from depression in the past.

The study showed that during a mean of 7.1 years of follow-up, 658 participants (19.3%) developed dementia.

At baseline, 321 participants (9.4%) had significant symptoms of depression, and 21.2% reported a history of depression.

After adjusting for age, sex, wave of enrolment, and educational level, the researchers found that participants who had a depression score higher than 11 had a 71% higher risk for dementia (hazard ratio [HR], 1.71; 95% confidence interval [CI], 1.37 – 2.13).

In addition, the study showed that late-life depression, occurring after the age of 50 years, was associated with an increased risk for all-cause dementia (adjusted HR, 1.46; 95% CI, 1.16 – 1.84). However, early-life depression, occurring before the age of 50 years, was not associated with dementia risk (adjusted HR, 1.10; 95% CI, 0.83 – 1.47).

“We think that depression in later life might be an early manifestation of dementia. Our results confirm that late-life depression is linked to an increased risk of dementia, so if you have a long history of depression, that is probably not causing the dementia. It is more due to something happening in later life,” said Dr. Li.

Intervention Studies the “Next Step”

By the time someone meets the criteria for dementia, the disease is in its late stages. Early diagnosis, therefore, is very important, Dr. Li added.

“If depressive symptoms could be an early sign of dementia, this raises the possibility that we might be able to intervene at an earlier stage, where we might have some impact on the outcome,” she said.

Anton P. Porteinsson, MD, William B. and Sylvia Konar professor of psychiatry at the University of Rochester School of Medicine and Dentistry, New York, agreed that treating late-life depression might be a way of slowing the progression to dementia.

“We need to do observational clinical trials, but it seems to make sense. It’s pretty clear that depression and dementia, the most common neuropsychiatric disorders in the elderly, often co-occur, and this co-occurrence exceeds chance,” he told Medscape Medical News. “Depression clearly signals a higher risk of developing both mild cognitive impairment and dementia.”

Dr. Porteinsson pointed out that in the Alzheimer’s Disease Neuroimaging Initiative study, the presence of depressive symptoms correlated with brain atrophy and white matter damage in the brain.

“We don’t know the mechanism and the causative factors, but the correlation is there,” he said.

Also not yet known is whether treating the depression will mitigate the risk of progressing to dementia.

“That’s going to be the next thing for us to discover. Certainly there are short-term benefits in terms of quality of life, but are there also going to be long-term benefits in terms of better disease load and dementia risk? This is what we need to discover.”

Dr. Li and Dr. Porteinsson have disclosed no relevant financial relationships.

From Medscape Medical News > Psychiatry

Enhanced by Zemanta

Understanding Alzheimer’s Disease

Via Scoop.itHealthcare Continuing Education
Understanding Alzheimer's Disease
Free resource from the National Institute on Aging

Many older people forget someone’s name or misplace things from time to time. This kind of forgetfulness is normal. But, forgetting how to get home, getting confused in places a person knows well, or asking questions over and over can be signs of a more serious problem. The person may have Alzheimer’s disease, a disease of the brain that begins slowly and gets worse over time.

This colorful, easy-to-read booklet helps readers learn about Alzheimer’s disease:

  • What it is
  • Signs of the disease
  • When it is important to see a doctor
  • Treatment
  • Research studies
  • How to get help caring for a person with the disease

Show original

Enhanced by Zemanta

Alzheimer’s Continuing Education

Alzheimer's Continuing Education

Click on image to view courses

Alzheimer’s currently affects one in 10 people over age 65 and nearly half of those individuals over 85. With such an outlook, it’s imperative that healthcare professionals stay current on the research and best practices for treatment and caregiving.

Professional Development Resources offers online continuing education courses to address this growing topic:

Alzheimer’s Disease & Related Disorders (ADRD) – This course provides an in-depth discussion of the management of Alzheimer’s Disease or Related Disorders (ADRD), including disease progression and strategies for care. It considers all aspects of ADRD, including the various stages of the disease, problem behaviors, communication issues, ethical considerations and appropriate activities. In addition, strategies are presented for working with families and caregivers of ADRD patients. 2006 | 47 pages | 27 posttest questions | 3 hours CE

Alzheimer’s Disease: Nutrition Intervention Strategies – Alzheimer’s disease is a disorder of forgetfulness that eventually impacts a person’s ability to participate in activities of daily living. It takes a devastating toll on both patients and those who care for them. Those with Alzheimer’s disease experience immense fear and frustration as they struggle with simple tasks. Family, friends, and caregivers experience pain and stress as they watch Alzheimer’s disease slowly take their loved ones away from them. Many individuals with Alzheimer’s disease and other forms of dementia are cared for in institutional settings. Nutrition plays an important role in meeting the needs of such persons. This course will familiarize readers with the early warning signs of dementia, discuss the pathophysiology of Alzheimer’s disease, identify pharmacological, environmental, and behavioral interventions used at various stages of the disease, and describe nutrition-related complications and intervention strategies. 2002 | 15 pages | 12 posttest questions | 2 hours CE

Alzheimer’s Disease – Overview – Alzheimer’s disease is an increasing concern for the aging American population. It is important for healthcare providers to have a basic familiarity with the disease, in order to provide adequate diagnosis, treatment, and referrals. This course, based on documents from the National Institute on Aging and the Alzheimer’s Association, provides an overview of the prevalence, causes, symptoms, diagnosis, treatment, and progression of Alzheimer’s disease, as well as information about caregiving and caregiver support. As such, this course is relevant to all clinicians who work with elderly individuals, their families, and their caretakers. Course #10-39 | 2010 | 34 pages | 7 posttest questions | 1 hour CE

Alzheimer’s – Unraveling the MysteryAlzheimer’s dementia is a growing concern among the aging Baby Boomers; yet, modern science points the way to reducing the risks through maintaining a healthy lifestyle. This course is based on a publication from the National Institute on Aging, which describes healthy brain functioning during the aging process and then contrasts it to the processes of Alzheimer’s disease. Full of colorful, detailed diagrams, this educational booklet describes the risk factors for Alzheimer’s disease, effective steps for prevention, strategies for diagnosing and treating Alzheimer’s disease, and the search for new treatments. Strategies for caregivers and reducing caregiver stress are also discussed briefly. Course #30-54 | 2008 | 43 pages | 21 posttest questions | 3 hours CE

Caring for a Person with Alzheimer’s Disease – This course is based on the public-access publication, Caring for a Person with Alzheimer’s Disease: Your Easy-to-Use Guide from the National Institute on Aging. The booklet discusses practical issues concerning caring for someone with Alzheimer’s disease, including a description of common challenges and coping strategies. Advice is provided regarding keeping the person safe, providing everyday care, adapting activities to suit their needs, and planning ahead for health, legal, and financial issues. Chapters also discuss self-care for caregivers, sources of assistance for caregivers in need, residential options for care, common medical issues, and end-of-life care. This course is relevant to clinicians who work with elderly individuals, their families, and their caretakers. Course #30-59 | 2010 | 146 pages | 22 posttest questions | 3 hours CE

Professional Development Resources is recognized as a provider of continuing education by the following:
AOTA: American Occupational Therapy Association (#3159)
APA: American Psychological Association
ASHA: American Speech-Language-Hearing Association (AAUM)
ASWB: Association of Social Work Boards (#1046)
CDR: Commission on Dietetic Registration (#PR001)
NBCC: National Board for Certified Counselors (#5590)
NAADAC: National Association of Alcohol & Drug Abuse Counselors (#00279)
California: Board of Behavioral Sciences (#PCE1625)
Florida: Boards of SW, MFT & MHC (#BAP346); Psychology & School Psychology (#50-1635); Dietetics & Nutrition (#50-1635); Occupational Therapy Practice (#34). PDResources is CE Broker compliant.
Illinois: DPR for Social Work (#159-00531)
Ohio: Counselor, Social Worker & MFT Board (#RCST100501)
South Carolina: Board of Professional Counselors & MFTs (#193)
Texas: Board of Examiners of Marriage & Family Therapists (#114) and Board of Social Worker Examiners (#5678)
Enhanced by Zemanta